MX2020013857A - Bacterias bifidobacterium bifidum no viables y usos de las mismas. - Google Patents
Bacterias bifidobacterium bifidum no viables y usos de las mismas.Info
- Publication number
- MX2020013857A MX2020013857A MX2020013857A MX2020013857A MX2020013857A MX 2020013857 A MX2020013857 A MX 2020013857A MX 2020013857 A MX2020013857 A MX 2020013857A MX 2020013857 A MX2020013857 A MX 2020013857A MX 2020013857 A MX2020013857 A MX 2020013857A
- Authority
- MX
- Mexico
- Prior art keywords
- bifidobacterium bifidum
- therapy
- treating
- bacteria
- relates
- Prior art date
Links
- 241000186016 Bifidobacterium bifidum Species 0.000 title abstract 3
- 241000894006 Bacteria Species 0.000 abstract 4
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 3
- 208000010643 digestive system disease Diseases 0.000 abstract 3
- 208000018685 gastrointestinal system disease Diseases 0.000 abstract 3
- 238000002560 therapeutic procedure Methods 0.000 abstract 3
- 229940002008 bifidobacterium bifidum Drugs 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/517—Bifidum
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Animal Husbandry (AREA)
- Physiology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
La presente invención se relaciona con bacterias no viables de la cepa de SYN-HI-001 de Bifidobacterium bifidum depositada bajo el No. de depósito DSM 24514 o uno o más fragmentos de las mismas, para usarse en terapia, particularmente para usarse en el tratamiento de un trastorno gastrointestinal, como síndrome del intestino irritable.Además, la presente invención se relaciona con una composición que comprende, como un ingrediente activo, las bacterias no viables para usarse en terapia, particularmente para usarse en el tratamiento de un trastorno gastrointestinal. Además, la presente invención se relaciona con un método de preparación de bacterias no viables de la cepa de SYN-HI-001 de Bifidobacterium bifidum depositada bajo el No. de depósito DSM 24514 o uno o más fragmentos de las mismas y una bacteria obtenida por el método de la invención para usarse en terapia, particularmente para usarse en el tratamiento de un trastorno gastrointestinal.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18179382 | 2018-06-22 | ||
| PCT/EP2019/066448 WO2019243563A1 (en) | 2018-06-22 | 2019-06-21 | Non-viable bifidobacterium bifidum bacteria and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020013857A true MX2020013857A (es) | 2021-03-25 |
Family
ID=62778713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020013857A MX2020013857A (es) | 2018-06-22 | 2019-06-21 | Bacterias bifidobacterium bifidum no viables y usos de las mismas. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210268041A1 (es) |
| EP (1) | EP3810161A1 (es) |
| JP (1) | JP2021528998A (es) |
| CN (1) | CN112312920A (es) |
| AU (1) | AU2019289987A1 (es) |
| BR (1) | BR112020025765A2 (es) |
| CA (1) | CA3100821A1 (es) |
| MX (1) | MX2020013857A (es) |
| WO (1) | WO2019243563A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110468061B (zh) * | 2018-05-11 | 2024-03-08 | 韩国亿诺生物有限公司 | 具有预防或治疗癌症的效果的新型菌株 |
| CN114949007A (zh) * | 2022-07-04 | 2022-08-30 | 南昌大学第一附属医院 | 假长双歧杆菌在制备防治胰腺炎药物中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990014837A1 (en) | 1989-05-25 | 1990-12-13 | Chiron Corporation | Adjuvant formulation comprising a submicron oil droplet emulsion |
| CN101134051A (zh) * | 2006-11-17 | 2008-03-05 | 青岛东海药业有限公司 | 酪酸梭菌、凝结芽孢杆菌、双歧杆菌在制备治疗肠易激综合征、冷凉泻、喝酒泻药物中的应用 |
| EP2481299B1 (en) * | 2011-01-31 | 2016-12-07 | Dr. Fischer Gesundheitsprodukte GmbH | Bifidobacterium bifidum strains for application in gastrointestinal diseases |
| KR101473421B1 (ko) * | 2013-02-28 | 2014-12-19 | 충청대학 산학협력단 | 과민성대장증후군 개선용 조성물 |
| MY188694A (en) * | 2015-05-29 | 2021-12-23 | Meiji Co Ltd | Anticariogenic agent and anticariogenic composition |
| CN107485625A (zh) * | 2017-07-06 | 2017-12-19 | 南昌大学 | 两歧双歧杆菌wbbj01的新应用 |
-
2019
- 2019-06-21 JP JP2021520463A patent/JP2021528998A/ja active Pending
- 2019-06-21 US US17/253,320 patent/US20210268041A1/en active Pending
- 2019-06-21 AU AU2019289987A patent/AU2019289987A1/en active Pending
- 2019-06-21 CA CA3100821A patent/CA3100821A1/en active Pending
- 2019-06-21 BR BR112020025765-6A patent/BR112020025765A2/pt unknown
- 2019-06-21 WO PCT/EP2019/066448 patent/WO2019243563A1/en unknown
- 2019-06-21 MX MX2020013857A patent/MX2020013857A/es unknown
- 2019-06-21 CN CN201980041722.2A patent/CN112312920A/zh active Pending
- 2019-06-21 EP EP19736607.3A patent/EP3810161A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019289987A1 (en) | 2020-12-24 |
| US20210268041A1 (en) | 2021-09-02 |
| CA3100821A1 (en) | 2019-12-26 |
| BR112020025765A2 (pt) | 2021-03-16 |
| JP2021528998A (ja) | 2021-10-28 |
| EP3810161A1 (en) | 2021-04-28 |
| CN112312920A (zh) | 2021-02-02 |
| WO2019243563A1 (en) | 2019-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SA517390513B1 (ar) | تركيبات تشتمل على سلالات بكتيرية | |
| PH12019501557A1 (en) | Bacillus isolates and uses thereof | |
| WO2018234793A3 (en) | Antibodies | |
| AU2020418312B2 (en) | Lactobacillus plantarum strain, and composition for preventing or treating metabolic diseases containing same | |
| AR106800A1 (es) | Composiciones que comprenden cepas bacterianas | |
| WO2018170351A8 (en) | Anti-phf-tau antibodies and uses thereof | |
| MX2016014807A (es) | Singenes de alfa(1,2)fucosiltransferasa para su utilizacion en la produccion de oligosacaridos fucosilados. | |
| WO2019099682A9 (en) | Compositions and methods for treating immune disorders using immune modulating lactococcus bacteria strains | |
| WO2016011562A8 (en) | A bacillus methylotrophicus strain and method of using the strain to increase drought resistance in a plant | |
| WO2016183532A8 (en) | Bacteria engineered to treat a disease or disorder | |
| MX2020006191A (es) | Bacteriocinas terapeuticas. | |
| SA113340703B1 (ar) | سلالة جديدة من بكتيريا Lactobacillus Crispatus | |
| PH12020551656A1 (en) | Growth differentiation factor 15 agonist compounds and methods of using the same | |
| MX2017008563A (es) | Novedoso bacteriófago esc-cop-1 de e. coli tipo f18 productora de toxina shiga y su uso para inhibir la proliferación de e. coli tipo f18 productora de toxina shiga. | |
| MX2022007999A (es) | Streptococcus thermophilus negativo a sacarosa para su uso en la preparación de productos fermentados. | |
| AU2016100865A4 (en) | Multi-strain probiotic composition | |
| MX2010003719A (es) | Vacuna de mycoplasma bovis y metodos de uso de la misma. | |
| WO2018088694A3 (ko) | 인위적으로 조작된 sc 기능 조절 시스템 | |
| MX2020013857A (es) | Bacterias bifidobacterium bifidum no viables y usos de las mismas. | |
| WO2018004224A3 (ko) | 신규 스포리치아과 미생물 및 그의 용도 | |
| MX2023004869A (es) | Anticuerpos contra sars-cov-2 y usos de los mismos. | |
| MX2022000369A (es) | Cepa bacteriana de bifidobacterium bifidum, las composiciones de la misma y usos relacionados. | |
| WO2018230960A3 (ko) | 신규한 비피도박테리움 비피덤 균주 및 균주 유래 다당체 | |
| MX2021006682A (es) | Inhibidores de descarboxilasa para el tratamiento de la enfermedad de parkinson. | |
| WO2020123330A3 (en) | Anti-alpha-synuclein antibodies and uses thereof |